Last reviewed · How we verify
NCT05138913
Arthroscopic Treatment Combine With TXA for Elbow Stiffness
NA trial testing TXA in Tranexamic Acid in 80 participants. Status unknown.
30 December 2022
Quick facts
| Lead sponsor | Beijing Jishuitan Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 December 2020 |
| Primary completion | 30 December 2022 |
| Estimated completion | 30 December 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- TXA — full drug profile →
- Saline
Conditions studied
- Tranexamic Acid — all drugs for Tranexamic Acid →
- Elbow Stiffness — all drugs for Elbow Stiffness →
Sponsor
Beijing Jishuitan Hospital
Who can join
Adults 18 to 60, any sex, with Tranexamic Acid or Elbow Stiffness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a prospective randomized controlled study of different arthroscopic treatments for elbow stiffness combined with tranexamic acid(TXA) injection. The patients with stiffness were randomly divided into groups before the operation. After the arthroscopic operation was completed, they were divided into a local TXA injection group and a control group (normal saline) to perform additional operations for reduction of hemorrhage. In different time periods, the quantitative and qualitative indicators including pain, functional score, range of motion, level of Hemoglobin, the circumference of the limb 10cm above and below the elbow, amount of hemorrhage, etc. were compared between groups at the same time period to evaluate the difference in the effect of arthroscopic treatment combined with TXA on the treatment of reduction of hemorrhage. Determine the effectiveness of TXA.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05138913
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of TXA
Trials testing the same drug.
- NCT06781021 — The Effect of Tranexamic Acid Vs Torniquet on Visual Clarity in Knee Arthroscopic ACL Reconstruction · NA · enrolling by invitation
- NCT05957822 — Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery · Phase 4 · recruiting
Other recruiting trials for Tranexamic Acid
Currently open trials in the same condition.
- NCT07401394 — BAR-TAX - Tranexamic Acid in Bariatric Surgery. · NA · active not recruiting
- NCT07157631 — Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial · NA · recruiting
- NCT06657924 — Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery · Phase 2 · recruiting
Other Beijing Jishuitan Hospital trials
Trials by the same sponsor.
- NCT07311616 — A Study on the Effectiveness of Preventive Extensive Release of the Rotator Interval and Joint Capsule to Reduce Postope · NA · not yet recruiting
- NCT06756984 — Long-Term Outcomes of Different Surgical Techniques for Sacral Tarlov Cysts: A Prospective Cohort Study · not yet recruiting
- NCT06872034 — The Efficacy and Safety of Venostan in Promoting Postoperative Swelling Reduction in Patients With Ankle Fractures · NA · recruiting
- NCT06416631 — Artificial Intelligence Versus Maunal Planning in Robot Assisted Spinal Surgery · NA · not yet recruiting
- NCT06480214 — Research on Key Technology Development and Clinical Application of Small Interactive Spinal Endoscopic Surgery Robot · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05138913 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing Jishuitan Hospital
- Last refreshed: 1 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05138913.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing